India · Delayed Price · Currency is INR Cohance Lifesciences Statistics
Total Valuation
BOM:543064 has a market cap or net worth of INR 162.61 billion. The enterprise value is 164.58 billion.
| Market Cap | 162.61B |
| Enterprise Value | 164.58B |
Important Dates
The next confirmed earnings date is Wednesday, August 5, 2026.
| Earnings Date | Aug 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 382.57M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.36% |
| Shares Change (QoQ) | +2.22% |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | 23.75% |
| Float | 137.96M |
Valuation Ratios
The trailing PE ratio is 90.73 and the forward PE ratio is 58.58.
| PE Ratio | 90.73 |
| Forward PE | 58.58 |
| PS Ratio | 7.17 |
| PB Ratio | 4.03 |
| P/TBV Ratio | 6.43 |
| P/FCF Ratio | 109.55 |
| P/OCF Ratio | 44.15 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 38.54, with an EV/FCF ratio of 110.87.
| EV / Earnings | 91.83 |
| EV / Sales | 7.25 |
| EV / EBITDA | 38.54 |
| EV / EBIT | 68.67 |
| EV / FCF | 110.87 |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of 0.10.
| Current Ratio | 2.83 |
| Quick Ratio | 1.56 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | 0.94 |
| Debt / FCF | 2.70 |
| Interest Coverage | 6.44 |
Financial Efficiency
Return on equity (ROE) is 3.84% and return on invested capital (ROIC) is 4.30%.
| Return on Equity (ROE) | 3.84% |
| Return on Assets (ROA) | 2.67% |
| Return on Invested Capital (ROIC) | 4.30% |
| Return on Capital Employed (ROCE) | 4.71% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 18.72M |
| Profits Per Employee | 1.48M |
| Employee Count | 1,212 |
| Asset Turnover | 0.40 |
| Inventory Turnover | 1.29 |
Taxes
In the past 12 months, BOM:543064 has paid 569.20 million in taxes.
| Income Tax | 569.20M |
| Effective Tax Rate | 27.49% |
Stock Price Statistics
The stock price has decreased by -57.39% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -57.39% |
| 50-Day Moving Average | 434.73 |
| 200-Day Moving Average | 470.59 |
| Relative Strength Index (RSI) | 44.58 |
| Average Volume (20 Days) | 96,223 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:543064 had revenue of INR 22.69 billion and earned 1.79 billion in profits. Earnings per share was 4.68.
| Revenue | 22.69B |
| Gross Profit | 16.06B |
| Operating Income | 2.40B |
| Pretax Income | 2.07B |
| Net Income | 1.79B |
| EBITDA | 4.27B |
| EBIT | 2.40B |
| Earnings Per Share (EPS) | 4.68 |
Balance Sheet
The company has 3.26 billion in cash and 4.00 billion in debt, with a net cash position of -745.10 million.
| Cash & Cash Equivalents | 3.26B |
| Total Debt | 4.00B |
| Net Cash | -745.10M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 40.34B |
| Book Value Per Share | 102.03 |
| Working Capital | 11.82B |
Cash Flow
In the last 12 months, operating cash flow was 3.68 billion and capital expenditures -2.20 billion, giving a free cash flow of 1.48 billion.
| Operating Cash Flow | 3.68B |
| Capital Expenditures | -2.20B |
| Depreciation & Amortization | 1.87B |
| Net Borrowing | -1.13B |
| Free Cash Flow | 1.48B |
| FCF Per Share | n/a |
Margins
Gross margin is 70.79%, with operating and profit margins of 10.56% and 7.90%.
| Gross Margin | 70.79% |
| Operating Margin | 10.56% |
| Pretax Margin | 9.13% |
| Profit Margin | 7.90% |
| EBITDA Margin | 18.82% |
| EBIT Margin | 10.56% |
| FCF Margin | 6.54% |
Dividends & Yields
BOM:543064 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.36% |
| Shareholder Yield | 0.36% |
| Earnings Yield | 1.10% |
| FCF Yield | 0.91% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BOM:543064 is 514.00, which is 20.93% higher than the current price. The consensus rating is "Hold".
| Price Target | 514.00 |
| Price Target Difference | 20.93% |
| Analyst Consensus | Hold |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 13.91% |
| EPS Growth Forecast (3Y) | 34.08% |
Stock Splits
The last stock split was on September 25, 2020. It was a forward split with a ratio of 2.
| Last Split Date | Sep 25, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 7 |